Literature DB >> 14700094

Analysis of autoantibody repertoires in sera of patients with glaucoma.

S C Joachim1, F H Grus, N Pfeiffer.   

Abstract

PURPOSE: Glaucoma is the second cause of blindness worldwide. It is usually considered a neurodegenerative disease. There is evidence that an autoimmune mechanism is involved in the development of glaucoma in some patients. The aim of this study was to analyze the IgG autoantibody repertoires in sera of glaucoma patients and healthy subjects.
METHODS: A total of 82 patients were divided into four groups: healthy volunteers without any ocular disorders (CO, n = 30), patients with primary open-angle glaucoma (POAG, n = 19), ocular hypertension (OHT, n = 16), and normal tension glaucoma (NTG, n = 17). All groups were matched for age and gender. The sera of these patients were tested against Western blots of retinal antigens. Immunodetection was done using 4-chloro-1-naphthol staining. The autoantibody patterns were digitized and subsequently analyzed by multivariate statistical techniques.
RESULTS: All patients showed different, complex staining patterns of autoantibodies against retinal antigens. There was an increase in the number of peaks in sera of patients with primary open-angle glaucoma (POAG) compared to healthy subjects (CO). Including all peaks the analysis of discriminance revealed a statistically significant difference between the patterns of POAG compared to all other groups (p < 0.01). Sera of normal tension glaucoma (NTG) had no statistically different autoantibody pattern compared to those of control subjects.
CONCLUSIONS: In this study, we demonstrated a difference in the IgG autoantibody patterns of primary open-angle glaucoma patients compared to healthy subjects. However, the patterns were not significantly different in normal tension glaucoma compared to control subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14700094     DOI: 10.1177/1120672103013009-1003

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  12 in total

1.  Biomarkers for glaucoma: from the lab to the clinic.

Authors:  N Von Thun Und Hohenstein-Blaul; S Kunst; N Pfeiffer; F H Grus
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

2.  Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens.

Authors:  Stephanie C Joachim; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

Review 3.  Immunological mechanisms in glaucoma.

Authors:  F Grus; D Sun
Journal:  Semin Immunopathol       Date:  2008-03-11       Impact factor: 9.623

4.  Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens.

Authors:  Stephanie C Joachim; Jan Reichelt; Simone Berneiser; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-12       Impact factor: 3.117

5.  Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration.

Authors:  Stephanie C Joachim; Kai Bruns; Karl J Lackner; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-13       Impact factor: 3.535

6.  Serum Th1 and Th17 related cytokines and autoantibodies in patients with Posner-Schlossman syndrome.

Authors:  Jun Zhao; Wenchieh Chen; Xiaosheng Huang; Shiming Peng; Tianhui Zhu; Zhihui Deng; Ping Liang; Hui Chang; Bao Jian Fan
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

7.  A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial.

Authors:  Katrin Lorenz; Yvonne Scheller; Katharina Bell; Franz Grus; Katharina A Ponto; Felix Bock; Claus Cursiefen; Jens Flach; Marta Gehring; Tunde Peto; Rufino Silva; Yossi Tal; Norbert Pfeiffer
Journal:  Trials       Date:  2017-03-16       Impact factor: 2.279

8.  Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens.

Authors:  Stephanie C Joachim; Oliver W Gramlich; Panagiotis Laspas; Heiko Schmid; Sabine Beck; Harald D von Pein; H Burkhard Dick; Norbert Pfeiffer; Franz H Grus
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

9.  Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina.

Authors:  Oliver W Gramlich; Sabine Beck; Nadine von Thun Und Hohenstein-Blaul; Nils Boehm; Anika Ziegler; Jan M Vetter; Norbert Pfeiffer; Franz H Grus
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

Review 10.  New directions in the treatment of normal tension glaucoma.

Authors:  Brian J Song; Joseph Caprioli
Journal:  Indian J Ophthalmol       Date:  2014-05       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.